Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder

CNS Spectr. 2020 Aug;25(4):455-457. doi: 10.1017/S1092852919001020. Epub 2019 Jun 20.
No abstract available

Keywords: Atomoxetine; Chronic irritability; Depressive Disorders; Disruptive Mood Dysregulation Disorder; inhibitor of the norepinephrine transporter.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adrenergic Uptake Inhibitors / administration & dosage
  • Adrenergic Uptake Inhibitors / adverse effects
  • Adrenergic Uptake Inhibitors / therapeutic use*
  • Aggression
  • Atomoxetine Hydrochloride / administration & dosage
  • Atomoxetine Hydrochloride / adverse effects
  • Atomoxetine Hydrochloride / therapeutic use*
  • Attention
  • Child
  • Conduct Disorder / drug therapy*
  • Drug Tolerance
  • Female
  • Humans
  • Male

Substances

  • Adrenergic Uptake Inhibitors
  • Atomoxetine Hydrochloride